跳至主要内容
临床试验/NL-OMON47981
NL-OMON47981尚未招募不适用

Effects of vitamin K2 supplementation on [18]F-NaF PET/MRI in patients with carotid and coronary artery disease - INTRICATE

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * * Asymptomatic carotid artery disease on at least one side with a degree of
  • stenosis > 25% (according to on the ECST criteria). If the patient has a
  • symptomatic carotid artery disease on the contra-lateral side, he/she will
  • still be included in the study., iIf intensified medical treatment for this
  • symptomatic stenosis (e.g. statins, antiplatelet medication) was started * 6
  • month before inclusion of the patient, he/she will still be included in the
  • study. This protocol was chosen in order to widely assure a stable situation on
  • the plaque(s), which avoids an overspill from this medication on the assumed
  • effects of the vitamin K supplementation.
  • * Age older than 18 years
  • * Signed informed consent provided

排除标准

  • * Antiplatelet or cholesterol lowering medication started in the past 6 months
  • * Chronic or paroxysmal atrial fibrillation
  • * Presence or scheduled coronary or carotid revascularisation procedure (e.g.
  • stent implantation, coronary artery bypass graft, balloon-dilatation,
  • endarterectomy, angioplasty)
  • * History of myocardial infarction or stroke
  • * Malignant disease (except for treated basal-cell or squamous cell carcinoma)
  • * Use of vitamin K antagonists or any other anticoagulation treatment
  • * A life-expectancy < 1 year
  • * Claustrophobia
  • * Presence of a pacemaker, intra-cardiac defibrillator, or metallic implant
  • (e.g. vascular clip, neuro-stimulator, cochlear implant)
  • * Body weight > 130kg or body habitus that does not fit into the gantry
  • * Pregnancy or wish to become pregnant in the near future
  • * Breast feeding
  • * (History of) metabolic or gastrointestinal disease
  • * Use of vitamin K-containing supplements or vitamin K-rich foods (i.e. soya)
  • * Chronic inflammatory disease
  • * Systemic treatment or topical treatment likely to interfere with evaluation
  • of the study parameters

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验